<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int Urol Nephrol</journal-id><journal-id journal-id-type="iso-abbrev">Int Urol Nephrol</journal-id><journal-title-group><journal-title>International Urology and Nephrology</journal-title></journal-title-group><issn pub-type="ppub">0301-1623</issn><issn pub-type="epub">1573-2584</issn><publisher><publisher-name>Springer Netherlands</publisher-name><publisher-loc>Dordrecht</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3462920</article-id><article-id pub-id-type="publisher-id">77</article-id><article-id pub-id-type="doi">10.1007/s11255-011-0077-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Transferrin changes in haemodialysed patients</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Formanowicz</surname><given-names>Dorota</given-names></name><address><phone>+48-61-8546590</phone><fax>+48-61-8546599</fax><email>doforman@ump.edu.pl</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Formanowicz</surname><given-names>Piotr</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Department of Clinical Biochemistry, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland </aff><aff id="Aff2"><label>2</label>Institute of Computing Science, Poznan University of Technology, Piotrowo 2, 60-965 Poznan, Poland </aff><aff id="Aff3"><label>3</label>Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>11</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>3</day><month>11</month><year>2011</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2012</year></pub-date><volume>44</volume><issue>3</issue><fpage>921</fpage><lpage>921</lpage><permissions><copyright-statement>&#x000a9; Springer Science+Business Media, B.V. 2011</copyright-statement></permissions><related-article related-article-type="corrected-article" id="d29e70" ext-link-type="doi" xlink:href="10.1007/s11255-011-9947-4"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, B.V. 2012</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum to: Int Urol Nephrol DOI 10.1007/s11255-011-9947-4</title><p>The original version of this article unfortunately contained a mistake. Under the heading &#x0201c;Transferrin changes in haemodialysed patients&#x0201d; in the sentence &#x0201c;We included in the study only those mHD patients who met the following criteria: a stable clinical state, no recent thrombosis or acute infection, absence of inflammation, i.e. normal serum concentration of C-reactive protein, interleukin-1 and interleukin-6 and TNF-alpha, no comorbid iron metabolism disturbances at present, i.e. high serum ferritin and low serum iron level, without uncontrolled hypertension, no oral contraception in women of child-bearing age, stable and no more than twice the normal alanine aminotransferase and aspartate aminotransferase levels (upper range 45 U/l)&#x0201d; the phrase &#x0201c;absence of inflammation i.e. normal serum concentration of C-reactive protein, interleukin-1 and interleukin-6 and TNF-alpha&#x0201d; should be replaced by phrase &#x0201c;with presence of chronic inflammation, i.e. increased concentration of C-reactive protein, interleukin-1 and interleukin-6 and TNF-alpha&#x0201d; and the phrase &#x0201c;no comorbid iron metabolism disturbances at present, i.e. high serum ferritin and low serum iron level&#x0201d; should be replaced by the phrase &#x0201c;with the presence of comorbid iron metabolism disturbances at present, i.e. high serum ferritin and low serum iron level&#x0201d;.</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1007/s11255-011-9947-4.</p></fn></fn-group></back></article>